FAQs
What is the job title for this role at AstraZeneca?
The job title is Diagnostics Scientific Liaison – Gulf.
What is the primary focus of AstraZeneca as a company?
AstraZeneca is focused on the discovery, development, and commercialization of prescription medicines for serious diseases, particularly in therapeutic areas like Respiratory, Gastroenterology, Cardiovascular, Diabetes, and Oncology.
What are the main responsibilities of the Diagnostics Scientific Liaison?
The main responsibilities include managing scientific information, building relationships with opinion leaders, supporting testing access, contributing to brand and diagnostic strategy, and facilitating local clinical research.
What qualifications are essential for this role?
Essential qualifications include a university degree from medical or science departments, good command of written and spoken English, at least 2 years of experience in the Diagnostic Market and Clinical Testing Market (preferably in Oncology), and effective communication skills.
Is travel required for this position?
Yes, there is no restriction on frequent travel for this role.
Are there desirable qualifications for this position?
Yes, desirable qualifications include good strategic thinking, innovation, a Master's in molecular biology, ability to influence people, advanced organizational skills, and experience in budget management.
Where is this position located?
The position is based in the UAE.
What kind of environment does AstraZeneca promote?
AstraZeneca promotes an inclusive culture that champions diversity, collaboration, and is committed to lifelong learning, growth, and development.
How can potential candidates learn more about AstraZeneca?
Candidates can find out more by following AstraZeneca on social media platforms such as LinkedIn, Facebook, and Instagram.
Is previous experience in Oncology required for external candidates?
Yes, at least 2 years of experience in the Diagnostic Market is required, with a preference for Oncology experience for external candidates.
